From Genetic Discovery to Curative Medicines

The Advanced Therapies Stage follows the full end-to-end pipeline of discovery of cell and gene therapies, moving through to implementation in the health system. It covers therapeutic design, manufacturing, regulation and clinical delivery.

We also have a range of networking activities for people working in Advanced Therapies. Please see here for more information.

Loading
11:30
  1. What Do We Need to Get More Advanced Therapies to Patients?
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Claire Booth
    Claire Booth, Consultant Paediatric Immunologist, UCL Great Ormond Street Institute of Child Health
12:00
  1. Sponsored Slot Available
    Advanced Therapies Stage
    30 mins
12:30
  1. Panel Discussion: Designing the Next Generation of Rare Disease Therapies: From Advanced Genomics to AI-Enabled Therapeutic Innovation
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Tassos Georgiadis
    Tassos Georgiadis, SVP Discovery & Preclinical Development, MeiraGTx
    Speaker image for Dan O'Connor
    Dan O'Connor, Director, Regulatory Policy & Early Access, ABPI
    Speaker image for Killian Hanlon
    Killian Hanlon, CEO & Chief Scientist, Lir Therapeutics
    Speaker image for Deborah Richards
    Deborah Richards, VP & General Manager, UK & Ireland, Alexion, AstraZeneca Rare Disease
13:00
  1. Lunch & Networking Break
    Advanced Therapies Stage
    90 mins
14:30
  1. Design and Translation of Next Generation Delivery Vehicles for Advanced Therapeutics
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Molly Stevens
    Molly Stevens, John Black Professor of Bionanoscience, University of Oxford
15:00
  1. Sponsored Slot Available
    Advanced Therapies Stage
    30 mins
15:30
  1. Engineering the Next Generation of Immunotherapies: Lessons from the First Approved T Cell Receptor-Based Therapy
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Annelise Vuidepot
    Annelise Vuidepot, SVP, Chief Science & Technology Officer and UK Site Head, Immunocore
16:00
  1. Networking Break
    Advanced Therapies Stage
    30 mins
16:30
  1. From Plasmids to Patients: Manufacturing & Scaling the Next Generation of Advanced Therapies
    Advanced Therapies Stage
    30 mins
17:00
  1. Sponsored Slot Available
    Advanced Therapies Stage
    30 mins
17:30
  1. Panel Discussion: How Can We Bridge the Gap from Discovery to GMP Manufacturing?
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Lara Campana
    Lara Campana, SVP, Head of Research and Translational Science, Resolution Therapeutics
    Speaker image for Marion Hitchcock
    Marion Hitchcock, Managing Director, CGT Incubator, Bayer
    Speaker image for Victor Hernandez
    Victor Hernandez, CSO, Axovia Therapeutics
    Speaker image for Stuart Lowe
    Stuart Lowe, Head of Advanced Therapies, TTP
11:30
  1. Building System Readiness for Disruptive Medicines in Wales
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Andrew Champion
    Andrew Champion, Programme Director, AWTTC
    Speaker image for Stephanie Francis
    Stephanie Francis, Programme Manager, AWTTC
12:00
  1. Sponsored Slot Available
    Advanced Therapies Stage
    30 mins
12:30
  1. The Acceleration of Therapies from Diagnosis to Delivery
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Jacqueline Barry
    Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy, Catapult
13:00
  1. Networking Lunch
    Advanced Therapies Stage
    70 mins
14:10
  1. De-risking ATMP Innovation & Streamlining Pathways to Deliver Better Outcomes for Patients
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for James Pound
    James Pound, MHRA
14:40
  1. How NICE Evaluates Gene Therapies and Recent Reflections
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for John Spoors
    John Spoors, Programme Director, Commercial, Managed Access and Medicines Policy, NICE
15:10
  1. The Psychological Journey of Gene Therapy for Haemophilia B Patients and Those Closed to Them
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Guy Maissis
    Guy Maissis, Clinical Psychologist, Royal Free London NHS Foundation Trust
15:40
  1. Networking Break
    Advanced Therapies Stage
    30 mins
16:10
  1. 25 Years of Gene Therapy for Inherited Immune Disorders: Progress and Future Potential
    Advanced Therapies Stage
    30 mins
    Speaker(s)
    Speaker image for Adrian Thrasher
    Adrian Thrasher, Professor in Paediatric Immunology and Wellcome Trust SRF, University College London
16:40
  1. Navigating MHRA Guidelines & Clinical Trial Regulations for ATMPs
    Advanced Therapies Stage
    40 mins
    Speaker(s)
    Speaker image for Kingyin Lee
    Kingyin Lee, Head of Clinical Trials, MHRA